Growth Metrics

AtriCure (ATRC) Share-based Compensation (2016 - 2025)

AtriCure (ATRC) has disclosed Share-based Compensation for 16 consecutive years, with $11.3 million as the latest value for Q4 2025.

  • Quarterly Share-based Compensation rose 8.43% to $11.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $44.7 million through Dec 2025, up 10.59% year-over-year, with the annual reading at $44.7 million for FY2025, 10.59% up from the prior year.
  • Share-based Compensation for Q4 2025 was $11.3 million at AtriCure, down from $12.4 million in the prior quarter.
  • The five-year high for Share-based Compensation was $12.4 million in Q3 2025, with the low at $6.6 million in Q1 2021.
  • Average Share-based Compensation over 5 years is $8.9 million, with a median of $8.9 million recorded in 2023.
  • The sharpest move saw Share-based Compensation soared 50.64% in 2021, then dropped 4.54% in 2022.
  • Over 5 years, Share-based Compensation stood at $7.5 million in 2021, then fell by 4.54% to $7.2 million in 2022, then grew by 29.39% to $9.3 million in 2023, then increased by 11.52% to $10.4 million in 2024, then rose by 8.43% to $11.3 million in 2025.
  • According to Business Quant data, Share-based Compensation over the past three periods came in at $11.3 million, $12.4 million, and $11.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.